3 Incredible Growth Stocks That Could Soar in 2024, According to Wall StreetThe Motley Fool • 01/16/24
Beam Therapeutics Highlights Progress Across Base Editing Portfolio and Outlines 2024 Anticipated MilestonesGlobeNewsWire • 01/08/24
Beam Therapeutics to Present at the 42nd Annual J.P. Morgan Healthcare ConferenceGlobeNewsWire • 01/02/24
Beam Therapeutics Appoints Biotech Executive Christi Shaw to its Board of DirectorsGlobeNewsWire • 12/14/23
Why Is Beam Therapeutics Inc. (BEAM) Up 29.5% Since Last Earnings Report?Zacks Investment Research • 12/08/23
Wall Street Analysts Believe Beam Therapeutics Inc. (BEAM) Could Rally 81.29%: Here's is How to TradeZacks Investment Research • 11/30/23
Right Now Could Be a Once-in-a-Generation Opportunity to Buy These Cathie Wood StocksThe Motley Fool • 11/14/23
Beam Therapeutics: Sale Of Rights To Verve's In-Vivo Candidates An Odd DecisionSeeking Alpha • 11/10/23
Does Beam Therapeutics Inc. (BEAM) Have the Potential to Rally 139.76% as Wall Street Analysts Expect?Zacks Investment Research • 11/10/23
Beam Therapeutics Reports Pipeline and Business Updates and Third Quarter 2023 Financial ResultsGlobeNewsWire • 11/08/23